What Happened?
South San Francisco, -based Ideaya-Biosciences Promoted Paul Stone as Chief Financial Officer and General Counsel
About the Company
Ideaya Biosciences is an oncology-focused biotechnology company committed to the discovery of personalized synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and immuno-oncology therapies targeting the tumor microenvironment. Founded in 2015, IDEAYA`s investors include 5AM Ventures (5AM), Canaan Partners (Canaan), Celgene, WuXi Healthcare Ventures (WuXi), Novartis Institute of Biomedical Research, and Alexandria Real Estate. The Company has assembled a world-class drug discovery team and Scientific Advisory Board (SAB) that is represented by a Nobel Laureate and three Members of the National Academy of Sciences. IDEAYA is located in South San Francisco and La Jolla, California.
About the Person
Paul Stone is Chief Financial Officer and General Counsel at Ideaya Biosciences. Previously, Paul held various senior legal leadership roles in the industry.
Info Source
News
Short Profile